Nkarta, Inc. Other Noncash Income (Expense)
Nkarta, Inc. (NKTX) reported Other Noncash Income (Expense) of $30.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2023-03-16
- Nkarta, Inc. other noncash income (expense) for the quarter ending 2020-12-31 was -$1.00K.
- Nkarta, Inc. other noncash income (expense) for fiscal 2021 was $30.00K, a 114.29% increase from fiscal 2020.
- Nkarta, Inc. other noncash income (expense) for fiscal 2020 was $14.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|
| 2021-12-31 | $30.00K 10-K · filed 2023-03-16 | ||
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $14.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $15.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |